This study will evaluate the safety and effects, good or bad of faricimab (Vabysmo®), a drug that is approved by the U.S. Food and Drug Administration (FDA) fo…

Presumed Ocular Histoplasmosis

~Estimated

~$10 – $5,625

Cincinnati Eye Institute, Southwest OhioNCT07695298

Phase 3

Histoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial (Histo-FACT)

The purpose of the study is threefold: 1. Assess the safety and efficacy of a single high-dose intravenous (LAmB 10mg/kg) compared to the SOC daily dosing (3m…

Histoplasmosis

~Estimated

~$10 – $6,250

University of MinnesotaNCT07261150